The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial
Open accessAbstract
Background: Surgical aortic valve replacement (SAVR) represents a class I indication in symptomatic patients with severe aortic stenosis (AS). However, indications for early SAVR in asymptomatic patients with severe AS and normal left ventricular function remain debated. Methods: The AVATAR trial (Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis) is an investigator-initiated international prospective randomized controlled trial that evaluated the safety and efficacy of early SAVR in the treatment of asymptomatic patients with severe AS, according to common criteria (valve area ≤1 cm 2 with aortic jet velocity >4 m/s or a mean transaortic gradient ≥40 mm Hg), and with normal left ventricular function. Negative exercise testing was mandatory for inclusion. The primary hypothesis was that early SAVR would reduce the primary composite end point of all-cause death, acute myocardial infarction, stroke, or unplanned hospitalization for heart failure compared with a conservative strategy according to guidelines. The trial was designed as event-driven to reach a minimum of 35 prespecified events. The study was performed in 9 centers in 7 European countries. Results: Between June 2015 and September 2020, 157 patients (mean age, 67 years; 57% men) were randomly allocated to early surgery (n=78) or conservative treatment (n=79). Follow-up was completed in May 2021. Overall median follow-up was 32 months: 28 months in the early surgery group and 35 months in the conservative treatment group. There was a total of 39 events, 13 in early surgery and 26 in the conservative treatment group. In the early surgery group, 72 patients (92.3%) underwent SAVR with operative mortality of 1.4%. In an intention-to-treat analysis, patients randomized to early surgery had a significantly lower incidence of primary composite end point than those in the conservative arm (hazard ratio, 0.46 [95% CI, 0.23–0.90]; P =0.02). There was no statistical difference in secondary end points, including all-cause mortality, first heart failure hospitalizations, major bleeding, or thromboembolic complications, but trends were consistent with the primary outcome. Conclusions: In asymptomatic patients with severe AS, early surgery reduced a primary composite of all-cause death, acute myocardial infarction, stroke, or unplanned hospitalization for heart failure compared with conservative treatment. This randomized trial provides preliminary support for early SAVR once AS becomes severe, regardless of symptoms. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02436655.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Self-citationMehran, R., Rao, S. V., Bhatt, D. L., Gibson, C. M., Caixeta, A., Eikelboom, J., Kaul, S., Wiviott, S. D., Menon, V., Nikolsky, E., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.009449 · Cited by 4,476
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Guidelines on the management of valvular heart disease (version 2012)
Authors/Task Force Members, Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., De Bonis, M., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs109 · Cited by 3,559
Self-citationBaumgartner, H., Hung, J., Bermejo, J., Chambers, J. B., Edvardsen, T., Goldstein, S., Lancellotti, P., LeFevre, M., Miller, F., & Otto, C. M. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.02.009 · Cited by 1,349
Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis
Rosenhek, R., Binder, T., Porenta, G., Lang, I., Christ, G., Schemper, M., Maurer, G., & Baumgartner, H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430903 · Cited by 1,338
Pellikka, P. A., Sarano, M. E., Nishimura, R. A., Malouf, J. F., Bailey, K. R., Scott, C. G., Barnes, M. E., & Tajik, A. J. (2005) · Circulation · doi:10.1161/circulationaha.104.495903 · Cited by 864
Pellikka, P. A., Nagueh, S. F., Elhendy, A. A., Kuehl, C. A., & Sawada, S. G. (2007) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.07.003 · Cited by 793
Iung, B., Delgado, V., Rosenhek, R., Price, S., Prendergast, B., Wendler, O., De Bonis, M., Tribouilloy, C., Evangelista, A., Bogachev-Prokophiev, A., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.041080 · Cited by 611
Self-citationEarly Surgery or Conservative Care for Asymptomatic Aortic Stenosis
Kang, D.-H., Park, S.-J., Lee, S.-A., Lee, S., Kim, D.-H., Kim, H.-K., Yun, S.-C., Hong, G.-R., Song, J.-M., Chung, C.-H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1912846 · Cited by 537
Cited by
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf194 · Cited by 1,072
Self-citationUlloa-Cerna, A. E., Jing, L., Pfeifer, J. M., Raghunath, S., Ruhl, J. A., Rocha, D. B., Leader, J. B., Zimmerman, N., Lee, G., Steinhubl, S. R., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057869 · Cited by 101
Calcific Aortic Stenosis: A Review
Otto, C. M., Newby, D. E., & Hillis, G. S. (2024) · JAMA · doi:10.1001/jama.2024.16477 · Cited by 97
Metadata
- Authors
- Banovic, M., Putnik, S., Penicka, M., Doros, G., Deja, M. A., Kockova, R., Kotrc, M., Glaveckaite, S., Gasparovic, H., Pavlovic, N., Velicki, L., Salizzoni, S., Wojakowski, W., Van Camp, G., Nikolic, S. D., Iung, B., Bartunek, J., Barbato, E., De Bruyne, B., Casselman, F., De Grieck, I., Heyse, A., Stockman, B., Vanderheyden, M., Van Durme, F., Van Praet, F., Wyffels, E., Biocina, B., Manola, S., Pirk, J., Cura-Stura, E., Rinaldi, M., Maria De Ferrari, G., Fava, A., Maria Richiardi, E., Celutkiene, J., Filipova, M., Ciosek, J., Guzy, M., Kurzelowski, R., Wojakowski, W., Bjelobrk, M., Ilic, A., Kovacevic, M., Miljkovic, T., Preveden, A., Srdanovic, I., Aleksandric, S., Asanin, M., Beleslin, B., Bojanic, M., Boskovic, N., Bosic, S., Cvetinovic, N., Dedovic, V., Giga, V., Jandric, P., Jaukovic, M., Jovanovic, M., Kovacevic-Kuzmanovic, A., Loncar, G., Manojlovic, A., Matkovic, M., Mitrovic, P., Nedeljkovic, I., Nedeljkovic, M., Petrovic, O., Ristic, A., Seper, M., Simic, D., Stankovic, S., Stojkovic, S., Vukcevic, V., & Zivic, K.
- Venue
- Circulation
- Published
- 2022-03
- Volume
- 145
- Issue
- 9
- Pages
- 648-658
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3212990746
- Cited by
- 307
- References
- 24
- FWCI
- 27.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial. https://app.cochat.ai/papers/10.1161/circulationaha.121.057639
- The paper
- Banovic, M., Putnik, S., Penicka, M., Doros, G., Deja, M. A., Kockova, R., Kotrc, M., Glaveckaite, S., Gasparovic, H., Pavlovic, N., Velicki, L., Salizzoni, S., Wojakowski, W., Van Camp, G., Nikolic, S. D., Iung, B., Bartunek, J., Barbato, E., De Bruyne, B., . . . Zivic, K. (2022). Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial. Circulation. https://doi.org/10.1161/circulationaha.121.057639
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.